250 related articles for article (PubMed ID: 15184100)
1. Gene-environment interplay in schizopsychotic disorders.
Palomo T; Archer T; Kostrzewa RM; Beninger RJ
Neurotox Res; 2004; 6(1):1-9. PubMed ID: 15184100
[TBL] [Abstract][Full Text] [Related]
2. [In search of susceptibility genes for schizophrenia].
Schosser A; Aschauer HN
Wien Klin Wochenschr; 2004 Dec; 116(24):827-33. PubMed ID: 15690966
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia as a disorder of neuroplasticity.
McCullumsmith RE; Clinton SM; Meador-Woodruff JH
Int Rev Neurobiol; 2004; 59():19-45. PubMed ID: 15006483
[TBL] [Abstract][Full Text] [Related]
4. Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.
Leriche L; Diaz J; Sokoloff P
Neurotox Res; 2004; 6(1):63-71. PubMed ID: 15184107
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
Guillin O; Demily C; Thibaut F
Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic control over brain dopamine release in vivo and in vitro.
Whitton PS
Neurosci Biobehav Rev; 1997 Jul; 21(4):481-8. PubMed ID: 9195606
[TBL] [Abstract][Full Text] [Related]
7. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.
Carlsson A; Waters N; Holm-Waters S; Tedroff J; Nilsson M; Carlsson ML
Annu Rev Pharmacol Toxicol; 2001; 41():237-60. PubMed ID: 11264457
[TBL] [Abstract][Full Text] [Related]
8. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.
Squires RF; Saederup E
Neurochem Res; 1991 Oct; 16(10):1099-111. PubMed ID: 1686635
[TBL] [Abstract][Full Text] [Related]
9. Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesis.
Inta D; Meyer-Lindenberg A; Gass P
Schizophr Bull; 2011 Jul; 37(4):674-80. PubMed ID: 21097511
[TBL] [Abstract][Full Text] [Related]
10. Cognitive endophenotypes, gene-environment interactions and experience-dependent plasticity in animal models of schizophrenia.
Burrows EL; Hannan AJ
Biol Psychol; 2016 Apr; 116():82-9. PubMed ID: 26687973
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment.
Walker J; Curtis V; Murray RM
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S11-9. PubMed ID: 12570067
[TBL] [Abstract][Full Text] [Related]
12. Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5.
Burrows EL; McOmish CE; Buret LS; Van den Buuse M; Hannan AJ
Neuropsychopharmacology; 2015 Jul; 40(8):1947-56. PubMed ID: 25666312
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Hyde TM; Crook JM
J Chem Neuroanat; 2001 Jul; 22(1-2):53-63. PubMed ID: 11470554
[TBL] [Abstract][Full Text] [Related]
14. GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.
Benamer N; Marti F; Lujan R; Hepp R; Aubier TG; Dupin AAM; Frébourg G; Pons S; Maskos U; Faure P; Hay YA; Lambolez B; Tricoire L
Mol Psychiatry; 2018 Mar; 23(3):691-700. PubMed ID: 28696429
[TBL] [Abstract][Full Text] [Related]
15. Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia.
Schwartz TL; Sachdeva S; Stahl SM
Curr Pharm Des; 2012; 18(12):1580-92. PubMed ID: 22280435
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia: diverse approaches to a complex disease.
Sawa A; Snyder SH
Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
[TBL] [Abstract][Full Text] [Related]
17. The environment and schizophrenia.
van Os J; Kenis G; Rutten BP
Nature; 2010 Nov; 468(7321):203-12. PubMed ID: 21068828
[TBL] [Abstract][Full Text] [Related]
18. Advances in schizophrenia.
Thaker GK; Carpenter WT
Nat Med; 2001 Jun; 7(6):667-71. PubMed ID: 11385502
[TBL] [Abstract][Full Text] [Related]
19. [Genetic hypothesis of schizophrenia].
Krebs MO
Rev Prat; 2002 Jun; 52(11):1208-11. PubMed ID: 12148206
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted genomic risk for brain function in schizophrenia.
Chen J; Calhoun VD; Pearlson GD; Ehrlich S; Turner JA; Ho BC; Wassink TH; Michael AM; Liu J
Neuroimage; 2012 Jul; 61(4):866-75. PubMed ID: 22440650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
